Back

The role of drug therapy in atrial fibrillation patients with heart failure and preserved left ventricular ejection fraction

31 August 2024 (11:30 - 11:45)
Organised by: Logo
Congress Presentation Part of: Treatment options for patients with atrial fibrillation and heart failure with preserved left ventricular function Atrial Fibrillation (AF) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Rosita Zakeri

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

3 More presentations in this session

Presentation thumbnail
The role of catheter ablation for atrial fibrillation in atrial fibrillation patients with heart failure and preserved left ventricular ejection fraction
Professor P. Sommer (Bad Oeynhausen, DE)
Slides Video
Presentation thumbnail
The role of AV nodal ablation and physiological pacing in atrial fibrillation patients with heart failure and preserved left ventricular ejection fraction
Professor M. Brignole (Milano, IT)
Slides Video
Presentation thumbnail
Treatment options for patients with atrial fibrillation and heart failure with preserved left ventricular function - discussion
Video

Access the full session

Session thumbnail
Treatment options for patients with atrial fibrillation and heart failure with preserved left ventricular function
Video

The Event

Event poster

ESC Congress 2024

31 August 2024 11:30 CET
You may be interested in
thumbnail
Congress Presentation
Optimal medical therapy of AF in HFpEF and HFrEF
thumbnail
Congress Session
Treatment options for patients with atrial fibrillation and heart failure with preserved left ventricular function
thumbnail
Congress Presentation
Highlights from session on atrial fibrillation and heart failure with preserved ejection fraction (HFpEF): managing a common combination

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources